A Cost-Effectiveness Analysis: First-Line Avelumab Plus...

Frontiers in Pharmacology 2020 / 5 Vol. 11

A Cost-Effectiveness Analysis: First-Line Avelumab Plus Axitinib Versus Sunitinib for Advanced Renal-Cell Carcinoma

Lu, Peiyao, Liang, Weiting, Li, Jiahao, Hong, Yanming, Chen, Zhuojia, Liu, Tao, Dong, Pei, Huang, Hongbing, Zhang, Tiantian, Jiang, Jie
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
11
Journal:
Frontiers in Pharmacology
DOI:
10.3389/fphar.2020.00619
Date:
May, 2020
File:
PDF, 712 KB
2020
Conversion to is in progress
Conversion to is failed